A citation-based method for searching scientific literature

Randi Ugleholdt, Marie-Louise H Poulsen, Peter J Holst, Jean-Claude Irminger, Cathrine Orskov, Jens Pedersen, Mette M Rosenkilde, Xiaorong Zhu, Donald F Steiner, Jens J Holst. J Biol Chem 2006
Times Cited: 71







List of co-cited articles
1265 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Inhibition of gastric inhibitory polypeptide signaling prevents obesity.
Kazumasa Miyawaki, Yuichiro Yamada, Nobuhiro Ban, Yu Ihara, Katsushi Tsukiyama, Heying Zhou, Shimpei Fujimoto, Akira Oku, Kinsuke Tsuda, Shinya Toyokuni,[...]. Nat Med 2002
639
35

Biology of incretins: GLP-1 and GIP.
Laurie L Baggio, Daniel J Drucker. Gastroenterology 2007
35


Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion.
Yukihiro Fujita, Rhonda D Wideman, Ali Asadi, Gary K Yang, Robert Baker, Travis Webber, Tianjiao Zhang, Rennian Wang, Ziliang Ao, Garth L Warnock,[...]. Gastroenterology 2010
116
30



Differential processing of pro-glucose-dependent insulinotropic polypeptide in gut.
Yukihiro Fujita, Ali Asadi, Gary K Yang, Yin Nam Kwok, Timothy J Kieffer. Am J Physiol Gastrointest Liver Physiol 2010
39
48

Stimulation of insulin secretion by gastric inhibitory polypeptide in man.
J Dupre, S A Ross, D Watson, J C Brown. J Clin Endocrinol Metab 1973
732
25

The physiology of glucagon-like peptide 1.
Jens Juul Holst. Physiol Rev 2007
22

GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine.
Kristine Mortensen, Louise Lundby Christensen, Jens Juul Holst, Cathrine Orskov. Regul Pept 2003
248
21


Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice.
K Miyawaki, Y Yamada, H Yano, H Niwa, N Ban, Y Ihara, A Kubota, S Fujimoto, M Kajikawa, A Kuroe,[...]. Proc Natl Acad Sci U S A 1999
357
21


Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia.
J J Meier, B Gallwitz, N Siepmann, J J Holst, C F Deacon, W E Schmidt, M A Nauck. Diabetologia 2003
222
19


Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes.
Victor A Gault, Nigel Irwin, Brian D Green, Jane T McCluskey, Brett Greer, Clifford J Bailey, Patrick Harriott, Finbarr P M O'harte, Peter R Flatt. Diabetes 2005
124
19

Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors.
R J Bollag, Q Zhong, P Phillips, L Min, L Zhong, R Cameron, A L Mulloy, H Rasmussen, F Qin, K H Ding,[...]. Endocrinology 2000
189
19

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans.
C Orskov, L Rabenhøj, A Wettergren, H Kofod, J J Holst. Diabetes 1994
733
18

Glucagon-like peptide-1 7-36: a physiological incretin in man.
B Kreymann, G Williams, M A Ghatei, S R Bloom. Lancet 1987
16



GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.
Paula L McClean, Nigel Irwin, Roslyn S Cassidy, Jens J Holst, Victor A Gault, Peter R Flatt. Am J Physiol Endocrinol Metab 2007
185
16

Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans.
Mikkel Christensen, Louise Vedtofte, Jens J Holst, Tina Vilsbøll, Filip K Knop. Diabetes 2011
203
16

Functional GIP receptors are present on adipocytes.
R G Yip, M O Boylan, T J Kieffer, M M Wolfe. Endocrinology 1998
176
15


Electronimmunocytochemical evidence for the K cell localization of gastric inhibitory polypeptide (GIP) in man.
A M Buchan, J M Polak, C Capella, E Solcia, A G Pearse. Histochemistry 1978
146
15

Reversal of islet GIP receptor down-regulation and resistance to GIP by reducing hyperglycemia in the Zucker rat.
Shalea Piteau, Amy Olver, Su-Jin Kim, Kyle Winter, John Andrew Pospisilik, Francis Lynn, Susanne Manhart, Hans-Ulrich Demuth, Madeleine Speck, Raymond A Pederson,[...]. Biochem Biophys Res Commun 2007
90
15

Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene.
R S Jackson, J W Creemers, S Ohagi, M L Raffin-Sanson, L Sanders, C T Montague, J C Hutton, S O'Rahilly. Nat Genet 1997
742
15

Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects.
Xiaorong Zhu, An Zhou, Arunangsu Dey, Christina Norrbom, Raymond Carroll, Chunling Zhang, Virginie Laurent, Iris Lindberg, Randi Ugleholdt, Jens J Holst,[...]. Proc Natl Acad Sci U S A 2002
260
15

Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency.
Robert S Jackson, John W M Creemers, I Sadaf Farooqi, Marie-Laure Raffin-Sanson, Andrea Varro, Graham J Dockray, Jens J Holst, Patricia L Brubaker, Pierre Corvol, Kenneth S Polonsky,[...]. J Clin Invest 2003
209
15

Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man.
R Eissele, R Göke, S Willemer, H P Harthus, H Vermeer, R Arnold, B Göke. Eur J Clin Invest 1992
464
15

GIP-(3-42) does not antagonize insulinotropic effects of GIP at physiological concentrations.
Carolyn F Deacon, Astrid Plamboeck, Mette M Rosenkilde, Jocelyn de Heer, Jens J Holst. Am J Physiol Endocrinol Metab 2006
46
23


A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents.
Brian Finan, Bin Yang, Nickki Ottaway, David L Smiley, Tao Ma, Christoffer Clemmensen, Joe Chabenne, Lianshan Zhang, Kirk M Habegger, Katrin Fischer,[...]. Nat Med 2015
353
15

Evidence of Extrapancreatic Glucagon Secretion in Man.
Asger Lund, Jonatan I Bagger, Nicolai J Wewer Albrechtsen, Mikkel Christensen, Magnus Grøndahl, Bolette Hartmann, Elisabeth R Mathiesen, Carsten P Hansen, Jan H Storkholm, Gerrit van Hall,[...]. Diabetes 2016
104
15

PLASMA INSULIN RESPONSE TO ORAL AND INTRAVENOUS GLUCOSE ADMINISTRATION.
H ELRICK, L STIMMLER, C J HLAD, Y ARAI. J Clin Endocrinol Metab 1964
681
14

Proglucagon is processed to glucagon by prohormone convertase PC2 in alpha TC1-6 cells.
Y Rouillé, G Westermark, S K Martin, D F Steiner. Proc Natl Acad Sci U S A 1994
176
14

Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.
Michael J Theodorakis, Olga Carlson, Spyros Michopoulos, Máire E Doyle, Magdalena Juhaszova, Kalliopi Petraki, Josephine M Egan. Am J Physiol Endocrinol Metab 2006
264
14

GIP(6-30amide) contains the high affinity binding region of GIP and is a potent inhibitor of GIP1-42 action in vitro.
R W Gelling, D H Coy, R A Pederson, M B Wheeler, S Hinke, T Kwan, C H McIntosh. Regul Pept 1997
50
20

NEW INTERPRETATION OF ORAL GLUCOSE TOLERANCE.
N MCINTYRE, C D HOLDSWORTH, D S TURNER. Lancet 1964
572
14

Effects of glucose-dependent insulinotropic peptide on osteoclast function.
Qing Zhong, Takashi Itokawa, Supriya Sridhar, Ke-Hong Ding, Ding Xie, Baolin Kang, Wendy B Bollag, Roni J Bollag, Mark Hamrick, Karl Insogna,[...]. Am J Physiol Endocrinol Metab 2007
137
14


Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors.
Tanya Hansotia, Laurie L Baggio, Dominique Delmeire, Simon A Hinke, Yuichiro Yamada, Katsushi Tsukiyama, Yutaka Seino, Jens J Holst, Frans Schuit, D J Drucker. Diabetes 2004
242
14


Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: possible contribution to impaired incretin effects in diabetes.
Gang Xu, Hideaki Kaneto, D Ross Laybutt, Valerie F Duvivier-Kali, Nitin Trivedi, Kiyoshi Suzuma, George L King, Gordon C Weir, Susan Bonner-Weir. Diabetes 2007
279
14

Reduced incretin effect in type 2 (non-insulin-dependent) diabetes.
M Nauck, F Stöckmann, R Ebert, W Creutzfeldt. Diabetologia 1986
907
14

Sequence of an intestinal cDNA encoding human gastric inhibitory polypeptide precursor.
J Takeda, Y Seino, K Tanaka, H Fukumoto, T Kayano, H Takahashi, T Mitani, M Kurono, T Suzuki, T Tobe. Proc Natl Acad Sci U S A 1987
90
14


Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2.
M Furuta, H Yano, A Zhou, Y Rouillé, J J Holst, R Carroll, M Ravazzola, L Orci, H Furuta, D F Steiner. Proc Natl Acad Sci U S A 1997
331
12



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.